Influence of the vascular endothelial growth factor on the development of severe pre-eclampsia or HELLP syndrome

Archives of Gynecology and Obstetrics

Volumn 284, Issue 3, 2011, Pages 551-557

  Bussen, Stefanie ^a   Bussen, Dieter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

HELLP syndrome; Pre eclampsia; Vascular endothelial growth factor

Indexed keywords

ESTRADIOL; ESTRIOL; PROGESTERONE; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; ESTRIOL BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; HYPOXIA; MATERNAL AGE; MATERNAL BLOOD; PATHOPHYSIOLOGY; PLACENTA FUNCTION; PLACENTAL HORMONAL FUNCTION; PLACENTAL HYPOXIA; PLACENTAL NUTRITIVE FUNCTION; PREECLAMPSIA; PRIMIPARA; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; BLOOD; CASE CONTROL STUDY; NONPARAMETRIC TEST; PREGNANCY;

ADULT; BIRTH WEIGHT; CASE-CONTROL STUDIES; ESTRADIOL; ESTRIOL; FEMALE; GESTATIONAL AGE; HELLP SYNDROME; HUMANS; MATERNAL AGE; PRE-ECLAMPSIA; PREGNANCY; PROGESTERONE; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84855996273     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-010-1704-x     Document Type: Article

References (44)

1. Yücesoy G, Ozkan S, Bodur H, Tan T, Caliskan E, Vural B, Corakci A (2005) Maternal and perinatal outcome in pregnancies complicated with hypertensive disorders of pregnancy: a seven year experience of a tertiary center. Arch Gynecol Obstet 273:43-49
2. Al-Suleiman SA, Qutub HO, Rahman J, Rahman MS (2006) Obstetric admissions to the intensive care unit: a 12-year-review. Arch Gynecol Obstet 274:4-8
3. Kawabata I, Nakai A, Takeshita T (2006) Prediction of HELLP syndrome with assessment of maternal dual hepatic blood supply by using Doppler ultrasound. Arch Gynecol Obstet 274:303-309 (Pubitemid 44127295)
4. Ozer A, Kanat-Pektas M, Ozer S, Tapisiz OL, Zulfikaroglu EE, Damnisman N (2009) The effect of betametasone treatment on clinical and laboratory features of pregnant women with HELLP syndrome. Arch Gynecol Obstet 280:65-70
5. Gasem T, Al Jama FE, Burshaid S, Rahman J, Al Suleiman SA, Rahman MS (2009) Maternal and fetal outcome of pregnancy complicated by HELLP syndrome. J Matern Fetal Neonatal Med 22:1140-1143
6. Ott J, Poschalko G, Zeisler H (2010) Severe early onset hemolysis, elevated liver enzyme, and low platelet-syndrome in 2 subsequent pregnancies: case report and review of the literature. Arch Gynecol Obstet 281:265-268
7. Young BC, Levine RJ, Karumanchi SA (2010) Pathogenesis of pre-eclampsia. Annu Rev Pathol 5:173-192
8. Myers LE, Baker PN (2002) Hypertensive diseases and preeclampsia. Curr Opin Obstet Gynecol 14:119-125
9. Myatt L, Webster RP (2009) Vascular biology of pre-eclampsia. J Thromb Haemost 7:375-384
10. Backe J, Bussen S, Steck T (1997) Significant decrease of maternal serum serotonin levels in singleton pregnancies complicated by severe pre-eclampsia or the HELLP-syndrome. Gynecol Endocrinol 11:405-409 (Pubitemid 28029583)
11. Bussen S, Sütterlin M, Steck T (1999) Plasma endothelin and big endothelin levels in women with severe pre-eclampsia or HELLP-syndrome. Arch Gynecol Obstet 262:113-119 (Pubitemid 29197074)
12. Hristoskova S, Holzgrewe W, Zhong XY, Hahn S (2008) Macrophage migration inhibiting factor is elevated in pregnancy but not to a greater extent in pre-eclampsia. Arch Gynecol Obstet 274:25-28
13. Catarino C, Rebelo I, Belo L, Rocha S, Castro EB, Patricio B, Quintanilha A, Santos-Silva A (2009) Fetal and maternal angiogentic/anti-angiogenetic factors in normal and pre-eclamptic pregnancy. Growth Factors 27:345-351
14. Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Edwin SS, Gomez R (2009) A prospective cohort study of the value of maternal plasma concentration of angiogenetic and anti-angiogenetic factors in early and midtrimester in the identification of patients destined to develop pre-eclampsia. J Matern Fetal Neonatal Med 22:1021-1038
15. Kalkunte S, Lai Z, Norris WE, Pietras LA, Tewari N, Boji R, Neubeck S, Markert UR, Sharma S (2009) Novel approaches for mechanistic understanding and predicting pre-eclampsia. J Reprod Immunol 83:134-138
16. Galazios G, Papazoglou D, Tsikouras P, Kolios D (2009) Vascular endothelial factor gene polymorphisms and pregnancy. J Matern Fetal Neonatal Med 22:371-378
17. Munaut C, Lorquet S, Pequeux C, Blacher S, Berndt S, Frankenne F, Foidart JM (2008) Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGF-1) but not for soluble endoglin induction in villous trophoblast. Hum Reprod 23:1407-1415 (Pubitemid 351770590)
18. Hoffmann P, Saoudi Y, Benharouga M, Graham CH, Schaal JP, Mazoumi C, Feige JJ, Alfaidy N (2009) Role of EG-VEGF in human placentation: physiological and pathological implications. J Cell Mol Med 13:2224-2235
19. Türkcüoglu I, Türkcüoglu P, Karabulut AB, Tasar A (2010) Vitreous vascular endothelial growth factor level during gestation. Arch Gynecol Obstet 281:417-421
20. Akolekar R, de Cruz J, Foidart JM, Munaut C, Nicolaides KH (2010) Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in pre-eclampsia. Prenat Diagn 30:191-197
21. Kupferminc MJ, Daniel Y, Englender T, Baram A, Many A, Jaffa AJ, Gull I, Lessing JB (1997) Vascular endothelial growth factor is increased in patients with pre-eclampsia. Am J Reprod Immunol 38:302-306 (Pubitemid 27427425)
22. Hayman R, Brockelsby J, Kenny L, Baker P (1999) Preeclampsia: the endothelium, circulating factors and VEGF. J Soc Gynecol Investig 6:3-10
23. Molvarec A, Szarka A, Walentin S, Szücs E, Nagy B, Rigó J (2010) Circulating angiogenetic factors determined by electrochemiluminescence in immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertension (in press). doi:10.1038/hr.2010.92
24. Akercan F, Cirpan T, Terek MC, Ozcakir HT, Giray G, Sagol S, Karadadas N (2008) The immunohistochemical evaluation of VEGF in placental biopsies of pregnancies complicated by preeclampsia. Arch Gynecol Obstet 272:109-114 (Pubitemid 350308026)
25. Sibai BM (1990) The HELLP syndrome: much ado about nothing? Am J Obstet Gynecol 162:911-915
26. Baker PN, Krasnow J, Roberts JM, Yeo KT (1995) Elevated serum levels of vascular endothelial growth factor in patients with pre-eclampsia. Obstet Gynecol 86:815-821
27. Vuorela-Vepsäläien P, Alfthan H, Orpana A, Alitalo K, Stenman UH, Halmesmäki E (1998) Vascular endothelial growth factor is bound in amniotic fluid and maternal serum. Hum Reprod 14:1346-1351
28. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis. Nature 359:843-845
29. Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T, Vartcovski L, Inser JM (1995) Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 279:1189-1195
30. Ahmed A, Dunk C, Ahmad S, Khaliq A (2000) Regulation of placental vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) and soluble Flt-1 by oxygen-a review. Placenta 21:S14-S24
31. Helske S, Vuorela P, Carpen O, Hornig C, Weich H, Hamesmäki E (2001) Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod 7:205-210 (Pubitemid 32148349)
32. Ranheim T, Staff AC, Henrikson T (2001) VEGF mRNA is unaltered in decidual and placental tissues in pre-eclampsia at delivery. Acta Obstet Gynecol 80:93-98 (Pubitemid 32113460)
33. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Atitalo K, Damsky C, Fisher S (2002) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe pre-eclampsia and hemolysis, elevated liver enzymes and low platelet syndrome. Am J Pathol 60:1405-1423 (Pubitemid 34411644)
34. Bosio PM, Wheeler T, Anthony F, Conro R, O'Herlihy C, McKenna P (2001) Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am J Obstet Gynecol 184:146-152 (Pubitemid 32141657)
35. Brockelsby JC, Anthony FW, Johnson IR, Baker PN (2000) The effects of vascular endothelial growth factor on endothelial cells: a potential role in pre-eclampsia. Am J Obstet Gynecol 182:176-183 (Pubitemid 30074389)
36. Reister F, Frank HG, Heyl W, Huppertz B, Kosanke W, Schröder P, Kaufmann P, Rath W (1997) Distribution of macrophages in the placental bed in pre-eclamptic patients. Placenta 18:A48-A49
37. Jelkmann W (2001) Pitfalls in measurements of circulating vascular endothelial factor. Clin Chem 47:617-623 (Pubitemid 32275802)
38. Wheeler T, Evans PW, Anthony FW, Godfrey KM, Howe DT, Osmond C (1999) Relationship between maternal serum vascular endothelial growth factor concentration in early pregnancy and fetal and placental growth. Hum Reprod 14:1619-1623 (Pubitemid 29265462)
39. Cooper JC, Sharkey AM, Charnock-Jones DS, Palmer CR, Smith SK (1996) VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 103:1191-1196 (Pubitemid 26402883)
40. Bányász I, Szabó S, Bokodi G, Vannay A, Vásárhelyi B, Szabó A, Tulassay T, Rigó J Jr (2006) Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia. Mol Hum Reprod 12:233-236 (Pubitemid 43779074)
41. Nagy B, Savli H, Molvarec A, Várkonyi T, Rigó B, Hupuczi P, Rigó J Jr (2008) Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses. Clin Chim Acta 389:126-131
42. Milne F, Redman C, Walker J, Baker P, Black R, Blincowe J, Cooper C, Fletcher G, Jokinen M, Moran PA (2009) Assessing the onset of pre-eclampsia: summary of the pre-eclampsia guideline (PRECOG II). BMJ 339:3129-3131
43. Huda SS, Freeman DJ, Nelson SM (2009) Short-and long-term strategies for the management of hypertensive disorders of pregnancy. Expert Rev Cardiovasc Ther 7:1581-1594
44. Evans PW, Wheeler T, Anthony F, Osmond C (1998) A longitudinal study of maternal serum vascular endothelial growth factor in early pregnancy. Hum Reprod 13:1057-1060